EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Profile and outcomes of Parkinson's disease deep brain stimulation in a public tertiary center in Brazil: retrospective cohort

Juan Sebastián Sánchez-León iD, Alexandre Baldissera iD, Giovana Zazo Guidio iD, Ingrid Lorena da Silva Gomes iD, Eduardo Drews Amorim iD, Leonardo Bedatti Koehler iD, Thomas Hugentobler Schlickmann iD, Thais Lampert Monte iD, Gabriela Magalhães Pereira iD, Paulo Petry Oppitz iD, Eduardo Goellner iD, Carlos Roberto de Mello Rieder iD und 3 weitere

Arquivos de Neuro-Psiquiatria · 01.06.2026 · 84 (06) · 001-008

DOI: 10.1055/s-0046-1825523 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Arquivos de Neuro-Psiquiatria, erschienen am 01.06.2026. Verfasst von Juan Sebastián Sánchez-León und 14 weiteren Autor:innen. Beteiligte Einrichtung: Hospital de Clínicas de Porto Alegre, Departamento de Neurologia, Porto Alegre RS, Brazil. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Parkinson Disease. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Deep brain stimulation (DBS) is an established surgical therapy for advanced Parkinson's disease (PD), but, in Latin America, access remains restricted, and local data are limited.

Objective

To describe the demographic, clinical, and procedural profile, as well as the treatment outcomes and perioperative complications, of patients undergoing DBS at a Brazilian reference center.

Methods

We conducted a retrospective observational study including 101 patients with PD who underwent bilateral DBS implantation between 2012 and 2024 at Hospital de Clínicas de Porto Alegre, Brazil, within the public healthcare system.

Results

The mean age at surgery was of 62.2 years; 63.4% of the patients were male. The mean ages at symptom onset, diagnosis, DBS indication, and surgery were of 43.1, 45.7, 54.5, and 56.7 years respectively. On average, the patients presented 10.9 years of disease duration when surgery was performed. Motor fluctuations (53.5%) and dyskinesias (41.6%) were the most common indications. The subthalamic nucleus (STN) was the predominant target (97%). Mild complications included wound infection (7.9%), while severe complications, such as lead migration, intracranial hemorrhage, or deep infection occurred in 6.9%. Levodopa equivalent daily dose (LEDD) was the primary outcome used to assess postoperative change; it was significantly reduced by ∼ 25% after DBS, from 1,885.6 to 1,406.7 mg at 12 months (Wilcoxon p < 0.001).

Conclusion

In the cohort of the present study, DBS was safe and enabled a sustained reduction in dopaminergic medication during follow-up. Despite these benefits, delays in surgery, limited access through the public health system, and device-availability issues continue to limit broader implementation, highlighting persistent structural inequalities in Latin America.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep Brain StimulationParkinson DiseaseHumansRetrospective StudiesMiddle AgedBrazilMaleFemaleTreatment OutcomeTertiary Care CentersAdultAged

Autor:innen und Institutionen

  • Hospital de Clínicas de Porto Alegre, Departamento de Neurologia, Porto Alegre RS, Brazil.
  • Universidade Federal do Rio Grande do Sul, Porto Alegre RS, Brazil.
  • Hospital de Clínicas de Porto Alegre, Research Organization Registry (ROR), Porto Alegre RS, Brazil.
  • Hospital de Clínicas de Porto Alegre, Departamento de Neurocirurgia, Porto Alegre RS, Brazil.
  • Hospital Santa Casa de Porto Alegre, Departamento de Neurologia, Porto Alegre RS, Brazil.

ORCID-Profile: Juan Sebastián Sánchez-León, Alexandre Baldissera, Giovana Zazo Guidio, Ingrid Lorena da Silva Gomes, Eduardo Drews Amorim, Leonardo Bedatti Koehler, Thomas Hugentobler Schlickmann, Thais Lampert Monte, Gabriela Magalhães Pereira, Paulo Petry Oppitz, Eduardo Goellner, Carlos Roberto de Mello Rieder, Artur Francisco Schumacher Schuh, Bruno Samuel Fraiman de Oliveira, Daniel Teixeira Dos Santos

Zitieren

APA

Sánchez-León, J. S., Baldissera, A., Guidio, G. Z., Gomes, I. L. D. S., Amorim, E. D., Koehler, L. B., Schlickmann, T. H., Monte, T. L., Pereira, G. M., Oppitz, P. P., Goellner, E., Rieder, C. R. M., Schuh, A. F. S., Oliveira, B. S. F., & Santos, D. T. D. (2026). Profile and outcomes of Parkinson's disease deep brain stimulation in a public tertiary center in Brazil: retrospective cohort. Arquivos de Neuro-Psiquiatria, 84(06), 001-008. https://doi.org/10.1055/s-0046-1825523

Vancouver

Sánchez-León JS, Baldissera A, Guidio GZ, Gomes ILDS, Amorim ED, Koehler LB, et al. Profile and outcomes of Parkinson's disease deep brain stimulation in a public tertiary center in Brazil: retrospective cohort. Arquivos de Neuro-Psiquiatria. 2026;84(06):001-008. doi:10.1055/s-0046-1825523

BibTeX
@article{SnchezLen2026,
  author = {Sánchez-León, Juan Sebastián and Baldissera, Alexandre and Guidio, Giovana Zazo and Gomes, Ingrid Lorena da Silva and Amorim, Eduardo Drews and Koehler, Leonardo Bedatti and Schlickmann, Thomas Hugentobler and Monte, Thais Lampert and Pereira, Gabriela Magalhães and Oppitz, Paulo Petry and Goellner, Eduardo and Rieder, Carlos Roberto de Mello and Schuh, Artur Francisco Schumacher and Oliveira, Bruno Samuel Fraiman de and Santos, Daniel Teixeira Dos},
  title = {Profile and outcomes of Parkinson's disease deep brain stimulation in a public tertiary center in Brazil: retrospective cohort},
  journal = {Arquivos de Neuro-Psiquiatria},
  year = {2026},
  volume = {84},
  number = {06},
  pages = {001--008},
  doi = {10.1055/s-0046-1825523}
}
Kostenlos starten →